ECM
MESO

ExodusPoint Capital Management’s Mesoblast MESO Stock Holding History

ExodusPoint Capital Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,854
Closed -$218K – 2212
2020
Q3 		$218K Buy
+5,854
New +$183K ﹤0.01% 1435

Other funds holding MESO

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

ExodusPoint Capital Management's MESO Position: Q4 2020 in Review

ExodusPoint Capital Management sold out of Mesoblast (MESO) in Q4 2020, closing a stake of 5,854 shares — an estimated $218K sold.

ExodusPoint Capital Management first reported a position in MESO in Q3 2020 and held it in 1 quarter. The position peaked at $218K in Q3 2020. 53 funds tracked by Wall St. Rank hold MESO as of Q4 2020.

  • ExodusPoint Capital Management reported no remaining Mesoblast position as of Q4 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 5,854 Mesoblast shares in Q4 2020, an estimated $218K.
  • ExodusPoint Capital Management first reported a position in Mesoblast in Q3 2020 and held it in 1 quarter.
  • ExodusPoint Capital Management's Mesoblast position peaked at $218K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held Mesoblast as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.